Who Should I Start? Chris Moore or Xavier Legette


Week 4 Projections

Fant.
Pts.
Rush.
Yds.
Rush
TD
Rec. Rec.
Yds.
Rec
TD
3.8 0.0 0.0 1.2 19.3 0.1

Chris Moore News

Chris Moore is Limited During Wednesday's Practice

Wednesday, September 23, 6:05 PM

Baltimore Ravens wide receiver Chris Moore (ankle) was a limited participant in practice on Wednesday. It sounds like Moore suffered an ankle injury during Sunday's loss to the New Orleans Saints. Moore was expected to have a bigger role in the passing attack with the Ravens banged up at wideout. He played 55 percent of the offensive snaps, but Moore finished with one reception on three targets for six yards. There's a chance that Moore remains a starter for the Week 3 matchup against the Dallas Cowboys. If he's out, Devontez Walker could see an elevated role. It's unlikely that either player does enough in the receiving game to warrant rostering in fantasy formats right now.


Week 4 Projections

Fant.
Pts.
Rush.
Yds.
Rush
TD
Rec. Rec.
Yds.
Rec
TD
0.0 0.0 0.0 0.0 0.0 0.0

Xavier Legette News

Xavier Legette Ruled Out for Week 4

Friday, October 2, 8:50 AM

Carolina Panthers wide receiver Xavier Legette (knee) has been ruled out for Week 4's matchup against the Detroit Lions. After missing all of practice this week, Legette will miss his second straight week due to the knee injury. In two games this season, he has caught two of six targets for 64 yards, playing 53% of snaps and running 61% of routes. With Legette out and Jalen Coker (quad) questionable, the Panthers could be thin at wide receiver behind second-year Tetairoa McMillan. With their bye week coming up in Week 5, Legette's next chance to return would be Week 6, when they travel to take on the Philadelphia Eagles.


Chris Moore vs. Xavier Legette

Still trying to decide between Moore and Legette? Check on the latest news to make sure both players are active and healthy. Our PPR projections show that Chris Moore is projected to score 3.8 points this week while Xavier Legette is projected to score 0.0 points.